Spire Healthcare Group (LON:SPI) Share Price Passes Above 50-Day Moving Average of $237.33

Spire Healthcare Group plc (LON:SPI)’s stock price crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 237.33 ($2.95) and traded as high as GBX 241 ($3.00). Spire Healthcare Group shares last traded at GBX 239 ($2.98), with a volume of 240,857 shares.

Analyst Ratings Changes

A number of equities analysts have weighed in on SPI shares. Berenberg Bank restated a “buy” rating and set a GBX 286 ($3.56) price objective on shares of Spire Healthcare Group in a research report on Thursday, February 29th. JPMorgan Chase & Co. restated an “overweight” rating and set a GBX 295 ($3.67) price objective on shares of Spire Healthcare Group in a research report on Monday, February 26th.

Spire Healthcare Group Price Performance

The stock’s 50-day moving average price is GBX 237.33 and its 200 day moving average price is GBX 228.76. The firm has a market capitalization of £960.60 million, a price-to-earnings ratio of 3,414.29, a PEG ratio of 1.06 and a beta of 0.99. The company has a quick ratio of 0.74, a current ratio of 0.69 and a debt-to-equity ratio of 170.37.

Spire Healthcare Group Increases Dividend

The firm also recently announced a dividend, which will be paid on Friday, June 21st. Stockholders of record on Thursday, May 23rd will be given a GBX 2.10 ($0.03) dividend. This represents a dividend yield of 0.89%. This is a boost from Spire Healthcare Group’s previous dividend of $0.50. The ex-dividend date is Thursday, May 23rd. Spire Healthcare Group’s dividend payout ratio is 4,285.71%.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.